Kelly Financial Services LLC Caladrius Biosciences, Inc. Transaction History

Kelly Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jul 17, 2024	SELL	$0.48 - $7.8 $4 - $78	-10 Closed	0 $0
Q3 2021 Jul 17, 2024	SELL	$1.15 - $1.57 $6 - $9	-6 Reduced 37.5%	10 $12,000
Q2 2021 Jul 17, 2024	BUY	$1.4 - $1.9 $8 - $11	6 Added 60.0%	16 $10,000
Q1 2019 Jul 17, 2024	BUY	$3.48 - $5.32 $34 - $53	10 New	10 $36,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.